top of page

Ewing Sarcoma Bone Cancer shrink in 2 months time

Ewing Sarcoma Bone Cancer

Uzbekistan, Tashken, At just 18 years old, the patient was diagnosed with a rare form of Ewing Sarcoma bone cancer and a secondary lesion in her leg (tibia). She underwent months of chemotherapy and radiotherapy, her tumour responded at first but later on the lesions resisted all treatment. Her brain tumor remained the same size, and her leg lesion continued to cause her intense pain, leading to mobility issues. Despite enduring these aggressive therapies, she felt she was running out of options, and her outlook seemed bleak. The constant headaches and leg pain had taken a severe toll on her physically and emotionally.


In a desperate condition, she was introduced to ECCT by her oncology, which she began with cautious hope. Remarkably, within just one week of starting ECCT, her severe headaches, which had been almost unbearable, began to diminish. Encouraged by this initial response, she continued the treatment diligently. After just 2 months of ECCT, her medical team ordered a follow-up MRI. To everyone’s surprise, the results showed that the large lesion in her head has cleared up finally, a milestone she hadn’t been able to achieve through months of chemotherapy and radiation.


Her progress didn’t stop there. She applied ECCT to the secondary lesion on her leg, which had resisted traditional treatments. Within weeks, the lesion began to shrink, and the pain that had previously left her unable to walk was noticeably reduced. Her mobility gradually improved, and she regained the ability to walk without the crippling pain that had once dominated her life.


This young woman’s journey highlights the importance of exploring innovative therapies like ECCT as complementary treatments, giving patients renewed possibilities and the chance for a better quality of life.

Comments


bottom of page